To test this idea, we evaluated Tfh cells (CD4+ICOS+PD-1hiCXCR5+) in peripheral blood specimens from patients with ICI-T1DM versus patients who received ICI therapy but did not develop IrAEs. Here, CD4 is linked to type 1 diabetes mellitus.